Inactive

The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement to procure a CVM-2024-121486 Establish-Preventative Maintenance Agreement (PMA), Base Yea... The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement to procure a CVM-2024-121486 Establish-Preventative Maintenance Agreement (PMA), Base Year plus Two (2) option years, for Q-Exactive SN05491L, under solicitation FDA-RFQ-CVM-2024. Changes: A few changes have been made to the RFQ. See attachment 0001